Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN35671014Phase 2Completed
Phase 2 trial of sodium cromoglycate in pruritus (6 arms), sponsored by Hewlett Healthcare. Primary endpoints: Change in severity of itch, Change in area of flare and blood flux and 1 more. Started Apr 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN35671014.